Elevation Oncology (NASDAQ:ELEV) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Elevation Oncology (ELEV) operate in?

Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Elevation Oncology Stock (NASDAQ: ELEV) stock price, news, charts, stock research, profile.

Open	$0.62
Close	$0.58
Volume / Avg.	2.50M / 757.75K
Day Range	$0.55 - $0.66
52 Wk Range	0.44 - 5.83
Market Cap	$35.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	10.96%
Days to Cover	13.73

Recent News

S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates

Avi Kapoor

Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday?

Elevation Oncology shares dropped after initial data from the Phase 1 trial of EO-3021 showed a 42.8% objective response rate in patients with advanced solid tumors expressing Claudin 18.2. No Grade 4 or 5 adverse events were reported. The company plans further trial expansion in 2025.

Vandana Singh

Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.62
Close	$0.58
Volume / Avg.	2.50M / 757.75K
Day Range	$0.55 - $0.66
52 Wk Range	0.44 - 5.83
Market Cap	$35.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	10.96%
Days to Cover	13.73

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Elevation Oncology (ELEV) stock?

You can purchase shares of Elevation Oncology (NASDAQ:ELEV) through any online brokerage.

View our list of the best stock brokerages

Who are Elevation Oncology (ELEV) competitors?

Other companies in Elevation Oncology’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX) and Barinthus Biotherapeutics (NASDAQ:BRNS).

What is the forecast, or price target, for Elevation Oncology (ELEV) stock?

Elevation Oncology has a consensus price target of $7.17.

What is the current price for Elevation Oncology (ELEV)?

The stock price for Elevation Oncology (NASDAQ: ELEV) is $0.608 last updated December 20, 2024 at 7:58 PM EST.

Does Elevation Oncology (ELEV) pay a dividend?

There are no upcoming dividends for Elevation Oncology.

When is Elevation Oncology (NASDAQ:ELEV) reporting earnings?

Elevation Oncology’s Q4 earnings are confirmed for Wednesday, March 5, 2025.

Is Elevation Oncology (ELEV) going to split?

There is no upcoming split for Elevation Oncology.

What sector and industry does Elevation Oncology (ELEV) operate in?

Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Elevation Oncology

Elevation Oncology (ELEV) Forecast